|
LOC728024 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.89209808615965E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.609400E-01 |
| Stage1-vs-Stage3 |
2.390600E-01 |
| Stage1-vs-Stage4 |
1.304870E-03 |
| Stage2-vs-Stage3 |
1.769400E-01 |
| Stage2-vs-Stage4 |
1.189980E-02 |
| Stage3-vs-Stage4 |
6.575900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.49519976797319E-10 |
| Normal-vs-Asian |
3.85247389544929E-14 |
| Caucasian-vs-AfricanAmerican |
8.680600E-01 |
| Caucasian-vs-Asian |
4.023400E-01 |
| AfricanAmerican-vs-Asian |
6.614400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.633590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.49859999998281E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.037400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.605600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.214400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.235700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.991400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.315400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.199800E-03 |
| Classical-VS-Follicular |
9.638400E-01 |
| Classical-VS-Other |
4.487400E-01 |
| Classical-VS-Normal |
1.62536650805123E-12 |
| Tall-VS-Follicular |
6.435900E-02 |
| Tall-VS-Other |
8.099800E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.360000E-01 |
| Follicular-VS-Normal |
1.69930736149126E-12 |
| Other-VS-Normal |
3.58380000000658E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.004300E-02 |
|
|
